New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 11, 2014
10:00 EDTQLGC, JOEZ, EMR, AFLYY, SIEGY, MPC, ITG, DRWI, RDS.A, LOGM, HFC, ECOMOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Air France-KLM (AFLYY) upgraded to Hold from Underperform at Jefferies... ChannelAdvisor (ECOM) upgraded to Buy from Hold at Deutsche Bank... DragonWave (DRWI) upgraded to Hold from Reduce at TD Securities... Emerson (EMR) upgraded to Buy from Hold at Argus... HollyFrontier (HFC) upgraded to Neutral from Sell at Citigroup... ITG (ITG) upgraded to Outperform from Market Perform at Keefe Bruyette... Joe's Jeans (JOEZ) upgraded to Buy from Neutral at B. Riley... LogMeln (LOGM) upgraded to Outperform from Market Perform at Cowen... Marathon Petroleum (MPC) upgraded to Buy from Neutral at Citigroup... QLogic (QLGC) upgraded to Equal Weight from Underweight at Morgan Stanley... Royal Dutch Shell (RDS.A) upgraded to Overweight from Neutral at JPMorgan... Siemens (SIEGY) upgraded to Outperform from Sector Perform at RBC Capital.
News For A;SIEGY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 21, 2015
10:13 EDTSIEGYSiemens awarded long-term service agreement for Brooklyn Navy Yard plant
Subscribe for More Information
May 20, 2015
16:29 EDTAAgilent appoints Rodney Gonsalves as principal accounting officer
Subscribe for More Information
May 19, 2015
08:23 EDTSIEGYSiemens bond plan keeps it in running for Halliburton assets, Bloomberg says
Subscribe for More Information
May 18, 2015
19:12 EDTAOn The Fly: After Hours Movers
Subscribe for More Information
17:15 EDTAAgilent down almost 5% after Q2 earnings results, guidance
16:10 EDTAAgilent sees FY15 EPS $1.67- $1.73, consensus $1.69
Subscribe for More Information
16:07 EDTAAgilent sees Q3 EPS 38c-42c, consensus 42c
Sees Q3 revenue $995M-$1.015B, consensus $1B.
16:06 EDTAAgilent reports Q2 EPS 38c, consensus 39c
Subscribe for More Information
15:00 EDTANotable companies reporting after market close
Subscribe for More Information
May 15, 2015
10:29 EDTSIEGYAmerican Urological Association to hold an annual meeting
Subscribe for More Information
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
May 13, 2015
08:08 EDTAAgilent volatility elevated into Q1 and sales outlook
Subscribe for More Information
07:31 EDTSIEGYHeart Rhythm Society to hold a conference
Heart Rhythm 2015 is being held in Boston on May 13-16.
May 12, 2015
09:23 EDTSIEGYBooz Allen, Siemens, Power Analytics to conduct feasibility study in NY
Subscribe for More Information
May 8, 2015
09:47 EDTSIEGYBrookings Institute / U.S. State Dept to hold a discussion
Brookings and U.S. Department of State hold a discussion entitled, "Bringing Driverless Cars from Research to International Markets" with Jessica Altschul, Manager of Outreach & Innovation Policy at Daimler and Karl-Josef Kuhn, Head of Reliable Automation and Control at Siemens Corporate Technology on May 8 at 10 am. Webcast Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use